ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1807

The Extent of Tubulointerstitial Inflammation in Lupus Nephritis Identifies Two Distinctive Subgroups: Impact on Inflammation Characteristics and Prognosis in Patients with Lupus Nephritis

Sang Jin Lee1, Eon Jeong Nam1, Man-Hoon Han2 and Yong Jin Kim2, 1Department of Internal Medicine, Kyungpook National University Hospital,, Daegu, Republic of Korea, 2Department of Pathology, Kyungpook National University Hospital,, Daegu, Republic of Korea

Meeting: ACR Convergence 2020

Keywords: Nephritis, prognostic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster III: Bench to Bedside

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Lupus nephritis is common clinical manifestation and contributes significantly to mortality in systemic lupus erythematosus (SLE). 

Recently several studies has been reported that severity of tubulointerstitial inflammation (TII) is associated with subsequent renal failure. However, it has not yet been reported histologic characteristics and prognosis by extent of TII in patients with lupus nephritis who had conventional treatment.

Methods: Ninety-four patients with lupus nephritis, who had conventional treatment and renal biopsy, were enrolled in this study. The extent of tubulointerstitial lymphocytic infiltrates was semi-quantitated (grade 1-4) using standard histochemical staining. Quantified apoptotic regulator protein, the B cell lymphoma 2 protein (Bcl-2), expressions in selected lymphocyte subsets were measured using novel computational approaches when applied to multicolor confocal images. Histologic characteristics and prognosis as well as clinical and laboratory characteristics were compared between mild (grade 1-2) and severe (graded 3-4) TII. Follow-up datas were obtained and survival analysis was carried out to determine.

Results: TII was a common pathologic finding, 61.7% percent of biopsy samples were graded as 1, 13.8% as 2, 14.9% as 3, and 9% as 4. When TII was divided into mild (grade 1-2) and severe (grade 3-4), patients with severe TII were significantly higher in serum creatinine, but not with double-stranded DNA (ds DNA) antibodies, serum complement 3/4, SLE disease activity (SLEDAI) and degree of proteinuria at the time of biopsies. Expression of bcl-2 and bcl-2 in CD4 positive cells were significantly higher in severe TII compared to in mild TII in lupus nephritis (p=0.040 and p=0.003, respectively) while those were not significant in IgA vasculitis. The mean follow-up time was 150.3 ± 7.0 months and overall, 9 patients died as a result of disease progression (n=6) and infection (n=3). Patients with severe TII were at greater risk for renal failure compared to those with mild TII (p=0.001). However, both glomerular proliferation and laboratory markers including baseline ds DNA, complement, SLEDAI and degree of proteinuria did not affect on long term renal failure. After multivariate logistic analysis including age and sex, severe TII provided poor prognostic information for renal failure (hazard ratio 4.5, 95% confidence interval 1.4–14.5; p = 0.011).

Conclusion: A significantly higher elevated bcl-2, especially in CD4 positve cells, was found in severe TII compared to mild TII in lupus nephritis whereas there was comparable bcl-2 expression in IgA vasculitis irrespective of inflammation extent. TII severity was independent predictor for a worse outcome in lupus nephritis patients with conventional treatment.

Figure 1


Disclosure: S. Lee, None; E. Nam, None; M. Han, None; Y. Kim, None.

To cite this abstract in AMA style:

Lee S, Nam E, Han M, Kim Y. The Extent of Tubulointerstitial Inflammation in Lupus Nephritis Identifies Two Distinctive Subgroups: Impact on Inflammation Characteristics and Prognosis in Patients with Lupus Nephritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-extent-of-tubulointerstitial-inflammation-in-lupus-nephritis-identifies-two-distinctive-subgroups-impact-on-inflammation-characteristics-and-prognosis-in-patients-with-lupus-nephritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-extent-of-tubulointerstitial-inflammation-in-lupus-nephritis-identifies-two-distinctive-subgroups-impact-on-inflammation-characteristics-and-prognosis-in-patients-with-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology